XIFIN Data Reveals COVID-19 Antibody Testing Volumes Surprisingly Low; Better Payor Coverage Needed to Support Testing Increase
As America returns to work, XIFIN shares update on nationwide COVID-19 testing volume and payor behavior during UBS expert event SAN DIEGO, Calif., — June 29, 2020 — Diagnostic laboratories continue to be a crucial part of nationwide efforts to provide access to COVID-19 testing, which is critical to managing the pandemic. XIFIN CEO Lâle White and Kyle Fetter, Executive Vice...
Utah Cancer Specialists Implements XIFIN VisualStrata to Provide Care Teams with Improved Data Insights
Award-winning precision medicine informatics platform integrates data from disparate systems to provide clinicians with greater patient insights and supports value-based care initiativesSAN DIEGO, Calif., — March 25, 2020 — Precision medicine is especially promising in oncology care, but the massive amounts of data that exists – often in silos – makes it challenging for clinicians to...
New XIFIN Data Reveals Routine Lab Volume Down Approximately 60% but Coronavirus Testing Adds Back Nearly 20%
Company introduces new weekly XIFIN Lab Volume Index; executives shared insights with UBS analysts during teleconference on lab testing activity and dynamics SAN DIEGO, Calif., — April 22, 2020 — Diagnostic laboratories are at the forefront of US efforts to assess the spread of COVID-19. Elective and non-urgent testing have been delayed as coronavirus testing has rolled out over the...
XIFIN Announces COVID-19 Advocacy Efforts to Support Diagnostic Labs in Response to Pandemic
Company joins COVID-19 Healthcare Coalition and creates independent resource center to provide laboratories with easy access to new payor data SAN DIEGO, Calif., — April 7, 2020 — The nature of public health outbreaks demands that health systems respond rapidly. Laboratory medicine experts have historically fulfilled this need by developing tests to accurately identify pathogens far...
XIFIN RPM 11 Provides Diagnostic Labs with Unmatched Insights and Automation to Improve Claim Accuracy and Reimbursement
Transformative RCM Platform Features Robust Automation, Including Denials and Appeals Management, Enhanced Self-Service, and Advanced Analytics and AI Options SAN DIEGO, Calif., — February 3, 2020 — Today’s diagnostic laboratory leaders face more challenges than ever – from increasing volumes to more rigorous payor requirements and changing PAMA reporting deadlines. To help lab leaders...
Study Finds Over 70% of Adopters Judge Precision Medicine Informatics Initiatives as Nearing or Exceeding Expectations
New Research from XIFIN and Journal of Precision Medicine Yields Promising Findings on the Value of PMI Initiatives SAN DIEGO, Calif., — December 11, 2019 — With more healthcare systems adopting and implementing precision medicine informatics (PMI) initiatives today, healthcare leaders are looking for insights around the emerging field to ensure they get the most value from their...
XIFIN Enhances Prior Authorization and Appeals Automation Capabilities to Improve Reimbursement for Diagnostic Providers
New partnership with Infinx addresses most prior authorization payor requirements through AI-driven automation and certified specialists for exception handling SAN DIEGO, Calif., — November 19, 2019 — XIFIN today announced prior authorization and appeals enhancements to its revenue cycle management platform XIFIN RPM, and a strategic partnership with Infinx to reduce the associated...
XIFIN Releases New Research Detailing Labs’ Role as Profit Catalysts for Health Systems to Support Value-Based Care, Compliance and Risk Mitigation
Third-party commissioned research explores the value of lab-specific RCM, and the benefits of actionable data and improved lab visibility for health systems SAN DIEGO, Calif., — November 6, 2019 — With the shift to value-based care and a realization that pre-existing enterprise solutions are suboptimal for laboratory revenue cycle management (RCM), the market is moving toward...
- 1 of 16
- next ›